CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
GLUCO-SCAN aims to develop a new imaging technique for cancer assessment using deuterium metabolic imaging. This method seeks to overcome the limitations of existing imaging technologies, providing a safer and more accessible alternative for whole-body cancer diagnosis.
The targeted scientific breakthrough of GLUCO-SCAN is the development and clinical evaluation of a disruptive whole-body molecular imaging concept for cancer assessment.
The only currently established whole-body molecular imaging device is positron emission tomography (PET).
Glucose (Glc)-sensitive PET is widely used in cancer diagnosis and treatment assessment, but has several major limitations:
PET involves harmful ionizing radiation, is expensive, not widely available, and cannot differentiat…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
